Internal Server Error

Sequome - About the company

Sequome is a series B company based in United States, founded in 2022 by Eeshit Dhaval Vaishnav. It operates as a Provider of decodes and designs sequences to develop sequence medicines. Sequome has raised $10.6M in funding. The company has 46 active competitors, including 6 funded and 9 that have exited. Its top competitors include companies like Droplet, Orphalan and Catalys Pacific.

Company Details

Provider of decodes and designs sequences to develop sequence medicines. Its refers to a series of ordered consequences that are directly linked to and result from a single cause. It also developing Gene Genie, an AI system for decoding and designing sequences.
Key Metrics
Founded Year
2022
Location
Stage
Series B
Total Funding
$10.6M in 1 round
Latest Funding Round
Ranked
Similar Companies
Sign up to download Sequome's company profile

Sequome's funding and investors

Sequome has raised a total funding of $10.6M over 1 round.

Here is the list of recent funding rounds of Sequome:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Jun 25, 2025
5910393
Series B
1695773
7711461
1431598
7995857
lockAccess funding benchmarks and valuations. Sign up today!

Sequome's founders and board of directors

Founder? Claim Profile
The founders of Sequome is Eeshit Dhaval Vaishnav. Eeshit Dhaval Vaishnav is the CEO of Sequome.
Here are the details of Sequome's key team members:
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Sequome's Competitors and alternates

Top competitors of Sequome include Droplet, Orphalan and Catalys Pacific. Here is the list of Top 10 competitors of Sequome, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Droplet
Droplet
2015, Gurugram (India), Acquired
Provider of home pathology sample collection and diagnostic tests services
$227K
43/100
2nd
Logo for Orphalan
Orphalan
2011, Paris (France), Funding Raised
Developer and provider of access to innovative treatments to patients with rare diseases
-
41/100
3rd
Provider of diagnostic healthcare investment services
-
-
40/100
4th
Logo for NIMBLE Diagnostics
NIMBLE Diagnostics
2022, Badalona (Spain), Seed
Developer of diagnostic device for the detection of cardiovascular conditions
$1.08M
40/100
5th
Logo for Isotopia-Global
Isotopia-Global
2007, Petah Tikva (Israel), Funding Raised
Manufacturer of radiopharmaceuticals, isotopes, radiotracers, and cold kits for medical uses
-
36/100
6th
Logo for Monarch Diagnostics
Monarch Diagnostics
2019, Irvine (United States), Unfunded
Provider of diagnostic testing services
-
-
35/100
7th
Logo for Shine Spect
Shine Spect
Janesville (United States), Unfunded
Provider of diagnostic radiopharmaceutical products and artificial intelligence solutions
-
-
34/100
8th
Logo for Sequome
Sequome
2022, United States, Series B
Provider of decodes and designs sequences to develop sequence medicines
$10.6M
-
31/100
9th
Logo for Nutrasource
Nutrasource
2002, Guelph (Canada), Acquired
Provider of marketing services for healthcare, nutraceutical & pharmaceutical sector
-
31/100
10th
Logo for Core Prescribing Solutions
Core Prescribing Solutions
2017, Bradford (United Kingdom), Unfunded
Healthcare organization providing clinical pharmacy services in primary care
-
-
31/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Sequome's competitors? Click here to see the top ones

Sequome's Investments and acquisitions

Sequome has made no investments or acquisitions yet.

FAQs about Sequome

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford